Kegg medicus dgroup
| DG01439 | |
| DG番号 | DG01439 |
| 分類 | DGroup |
| 名称 | Arabinofuranosyl type antineoplastic |
| ステム | -arabine, -citabine, -ribine TYPE Structure |
| 構造式 |  |
| メンバー | DG00685 Fludarabine D07966 Fludarabine (INN) D01907 Fludarabine phosphate (JAN/USP) D03546 Clofarabine (JAN/USAN/INN) D05134 Nelarabine (JAN/USAN/INN); Nelzarabine (USAN) DG00686 Cytarabine D00168 Cytarabine (JP18/USP/INN) D03046 Cytarabine ocfosfate hydrate (JAN) D03637 Cytarabine hydrochloride (USAN) DG00688 Gemcitabine D02368 Gemcitabine (USAN/INN) D01155 Gemcitabine hydrochloride (JAN/USP) D10222 Gemcitabine elaidate (USAN/INN) D03665 Decitabine (USAN/INN) D01633 Enocitabine (JAN/INN) DG03244 Fostroxacitabine D12451 Fostroxacitabine bralpamide (USAN/INN) D12452 Fostroxacitabine bralpamide hydrochloride (USAN) D01651 Ancitabine hydrochloride (JAN) D04134 Fazarabine (USAN/INN) D04233 Flurocitabine (USAN/INN) D06100 Tezacitabine (USAN) D06221 Triciribine phosphate (USAN) D06255 Troxacitabine (USAN/INN) D09712 Elacytarabine (USAN/INN) D09722 Sapacitabine (USAN/INN) D12387 Fosgemcitabine palabenamide (USAN/INN) |
| 上位グループ | Antineoplastic DG02018 Antimetabolite DG01958 Nucleic acid derivative, antineoplastic |
| 注釈1 | - |
| 注釈2 | - |